{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T10:23:09Z","timestamp":1774520589527,"version":"3.50.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100007109","name":"Universit\u00e0 degli Studi di Ferrara","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007109","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1007\/s00415-026-13739-8","type":"journal-article","created":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T14:59:40Z","timestamp":1773068380000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Beyond oligoclonal bands: the independent role of kappa free light chains in the diagnostic workup of multiple sclerosis"],"prefix":"10.1007","volume":"273","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-7895-7996","authenticated-orcid":false,"given":"Raffaella","family":"Candeloro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele","family":"Laudisi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caterina","family":"Ferri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eleonora","family":"Baldi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanna","family":"Negri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Ghisellini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maura","family":"Pugliatti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimiliano","family":"Castellazzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,9]]},"reference":[{"issue":"2","key":"13739_CR1","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/s1474-4422(17)30470-2","volume":"17","author":"AJ Thompson","year":"2018","unstructured":"Thompson AJ, Banwell BL, Barkhof F, Carroll WM, Coetzee T, Comi G et al (2018) Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol 17(2):162\u2013173. https:\/\/doi.org\/10.1016\/s1474-4422(17)30470-2. (Epub 20171221)","journal-title":"Lancet Neurol"},{"issue":"9648","key":"13739_CR2","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1016\/s0140-6736(08)61620-7","volume":"372","author":"A Compston","year":"2008","unstructured":"Compston A, Coles A (2008) Multiple sclerosis. Lancet 372(9648):1502\u20131517. https:\/\/doi.org\/10.1016\/s0140-6736(08)61620-7. (PubMed PMID: 18970977.)","journal-title":"Lancet"},{"issue":"1","key":"13739_CR3","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1080\/14737159.2017.1262260","volume":"17","author":"M Gastaldi","year":"2017","unstructured":"Gastaldi M, Zardini E, Franciotta D (2017) An update on the use of cerebrospinal fluid analysis as a diagnostic tool in multiple sclerosis. Expert Rev Mol Diagn 17(1):31\u201346. https:\/\/doi.org\/10.1080\/14737159.2017.1262260. (Epub 20161202)","journal-title":"Expert Rev Mol Diagn"},{"issue":"8","key":"13739_CR4","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1136\/jnnp.57.8.897","volume":"57","author":"M Andersson","year":"1994","unstructured":"Andersson M, Alvarez-Cerme\u00f1o J, Bernardi G, Cogato I, Fredman P, Frederiksen J et al (1994) Cerebrospinal fluid in the diagnosis of multiple sclerosis: a consensus report. J Neurol Neurosurg Psychiatry 57(8):897\u2013902. https:\/\/doi.org\/10.1136\/jnnp.57.8.897. (PubMed PMID: 8057110; PubMed Central PMCID: PMC1073070.)","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"5","key":"13739_CR5","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.it.2005.02.009","volume":"26","author":"A Uccelli","year":"2005","unstructured":"Uccelli A, Aloisi F, Pistoia V (2005) Unveiling the enigma of the CNS as a B-cell fostering environment. Trends Immunol 26(5):254\u2013259. https:\/\/doi.org\/10.1016\/j.it.2005.02.009. (PubMed PMID: 15866238.)","journal-title":"Trends Immunol"},{"issue":"10","key":"13739_CR6","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1016\/s1474-4422(25)00270-4","volume":"24","author":"X Montalban","year":"2025","unstructured":"Montalban X, Lebrun-Fr\u00e9nay C, Oh J, Arrambide G, Moccia M, Pia Amato M et al (2025) Diagnosis of multiple sclerosis: 2024 revisions of the McDonald criteria. Lancet Neurol 24(10):850\u2013865. https:\/\/doi.org\/10.1016\/s1474-4422(25)00270-4. (PubMed PMID: 40975101.)","journal-title":"Lancet Neurol"},{"issue":"1","key":"13739_CR7","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/0165-5728(95)00086-h","volume":"62","author":"KJ Lamers","year":"1995","unstructured":"Lamers KJ, de Jong JG, Jongen PJ, Kock-Jansen MJ, Teunesen MA, Prudon-Rosmulder EM (1995) Cerebrospinal fluid free kappa light chains versus IgG findings in neurological disorders: qualitative and quantitative measurements. J Neuroimmunol 62(1):19\u201325. https:\/\/doi.org\/10.1016\/0165-5728(95)00086-h. (PubMed PMID: 7499488.)","journal-title":"J Neuroimmunol"},{"issue":"11-12","key":"13739_CR8","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/j.cca.2011.03.007","volume":"412","author":"T Nakano","year":"2011","unstructured":"Nakano T, Matsui M, Inoue I, Awata T, Katayama S, Murakoshi T (2011) Free immunoglobulin light chain: its biology and implications in diseases. Clin Chim Acta 412(11\u201312):843\u2013849. https:\/\/doi.org\/10.1016\/j.cca.2011.03.007. (Epub 20110315)","journal-title":"Clin Chim Acta"},{"issue":"2","key":"13739_CR9","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1177\/13524585221134213","volume":"29","author":"H Hegen","year":"2023","unstructured":"Hegen H, Walde J, Berek K, Arrambide G, Gnanapavan S, Kaplan B et al (2023) Cerebrospinal fluid kappa free light chains for the diagnosis of multiple sclerosis: a systematic review and meta-analysis. Mult Scler 29(2):169\u2013181. https:\/\/doi.org\/10.1177\/13524585221134213. (Epub 20221201)","journal-title":"Mult Scler"},{"key":"13739_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics10100856","author":"D Ferraro","year":"2020","unstructured":"Ferraro D, Bedin R, Natali P, Franciotta D, Smolik K, Santangelo M et al (2020) Kappa index versus CSF oligoclonal bands in predicting multiple sclerosis and infectious\/inflammatory CNS disorders. Diagnostics (Basel). https:\/\/doi.org\/10.3390\/diagnostics10100856","journal-title":"Diagnostics (Basel)"},{"key":"13739_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25105412","author":"G Maglio","year":"2024","unstructured":"Maglio G, D\u2019Agostino M, Caronte FP, Pezone L, Casamassimi A, Rienzo M et al (2024) Multiple sclerosis: from the application of oligoclonal bands to novel potential biomarkers. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms25105412. (Epub 20240515)","journal-title":"Int J Mol Sci"},{"key":"13739_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics9040194","author":"P Schwenkenbecher","year":"2019","unstructured":"Schwenkenbecher P, Konen FF, Wurster U, Witte T, Gingele S, S\u00fchs KW et al (2019) Reiber\u2019s diagram for kappa free light chains: the new standard for assessing intrathecal synthesis? Diagnostics. https:\/\/doi.org\/10.3390\/diagnostics9040194. (Epub 20191116)","journal-title":"Diagnostics"},{"issue":"9","key":"13739_CR13","doi-asserted-by":"publisher","DOI":"10.1111\/ene.70355","volume":"32","author":"H Hegen","year":"2025","unstructured":"Hegen H, Schmidauer M, Auer M, Di Pauli F, Berek K, Walde J et al (2025) Kappa Free Light Chain Index in the real world-do we miss clinically relevant information by skipping oligoclonal banding? Eur J Neurol 32(9):e70355. https:\/\/doi.org\/10.1111\/ene.70355. (PubMed PMID: 40913362; PubMed Central PMCID: PMC12413532.)","journal-title":"Eur J Neurol"},{"issue":"4","key":"13739_CR14","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1001\/archneur.62.4.574","volume":"62","author":"LM Villar","year":"2005","unstructured":"Villar LM, Masjuan J, S\u00e1daba MC, Gonz\u00e1lez-Porqu\u00e9 P, Plaza J, Bootello A et al (2005) Early differential diagnosis of multiple sclerosis using a new oligoclonal band test. Arch Neurol 62(4):574\u2013577. https:\/\/doi.org\/10.1001\/archneur.62.4.574. (PubMed PMID: 15824255.)","journal-title":"Arch Neurol"},{"issue":"13","key":"13739_CR15","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1177\/1352458513488232","volume":"19","author":"C Teunissen","year":"2013","unstructured":"Teunissen C, Menge T, Altintas A, \u00c1lvarez-Cerme\u00f1o JC, Bertolotto A, Berven FS et al (2013) Consensus definitions and application guidelines for control groups in cerebrospinal fluid biomarker studies in multiple sclerosis. Mult Scler 19(13):1802\u20131809. https:\/\/doi.org\/10.1177\/1352458513488232. (Epub 20130521)","journal-title":"Mult Scler"},{"issue":"24","key":"13739_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics14242798","volume":"14","author":"R Candeloro","year":"2024","unstructured":"Candeloro R, Galloppa M, Lombardo L, Laudisi M, Ghisellini S, Negri G et al (2024) Kappa free light chains in multiple sclerosis as a marker of intrathecal humoral response: a sex-disaggregated study. Diagnostics 14(24):2798. https:\/\/doi.org\/10.3390\/diagnostics14242798","journal-title":"Diagnostics"},{"issue":"1","key":"13739_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s12987-020-0173-2","volume":"17","author":"M Castellazzi","year":"2020","unstructured":"Castellazzi M, Morotti A, Tamborino C, Alessi F, Pilotto S, Baldi E et al (2020) Increased age and male sex are independently associated with higher frequency of blood-cerebrospinal fluid barrier dysfunction using the albumin quotient. Fluids Barriers CNS 17(1):14. https:\/\/doi.org\/10.1186\/s12987-020-0173-2. (Epub 20200205)","journal-title":"Fluids Barriers CNS"},{"issue":"2","key":"13739_CR18","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0022-510x(94)90298-4","volume":"122","author":"H Reiber","year":"1994","unstructured":"Reiber H (1994) Flow rate of cerebrospinal fluid (CSF)--a concept common to normal blood-CSF barrier function and to dysfunction in neurological diseases. J Neurol Sci 122(2):189\u2013203. https:\/\/doi.org\/10.1016\/0022-510x(94)90298-4. (PubMed PMID: 8021703.)","journal-title":"J Neurol Sci"},{"key":"13739_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/biology13060420","author":"R Candeloro","year":"2024","unstructured":"Candeloro R, Ferri C, Bellini T, Pugliatti M, Castellazzi M (2024) Breaking barriers: unveiling sex-related differences in cerebrospinal fluid analysis-a narrative review. Biology (Basel). https:\/\/doi.org\/10.3390\/biology13060420. (Epub 20240605)","journal-title":"Biology (Basel)"},{"issue":"1","key":"13739_CR20","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-024-12826-y","volume":"272","author":"D Vecchio","year":"2024","unstructured":"Vecchio D, Puricelli C, Virgilio E, Passarelli F, Guida S, Naldi P et al (2024) Kappa index for multiple sclerosis diagnosis: an accurate biomarker of intrathecal synthesis. J Neurol 272(1):30. https:\/\/doi.org\/10.1007\/s00415-024-12826-y. (Epub 20241212)","journal-title":"J Neurol"},{"issue":"1","key":"13739_CR21","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/0165-5728(91)90035-6","volume":"33","author":"CJ Sindic","year":"1991","unstructured":"Sindic CJ, Laterre EC (1991) Oligoclonal free kappa and lambda bands in the cerebrospinal fluid of patients with multiple sclerosis and other neurological diseases. An immunoaffinity-mediated capillary blot study. J Neuroimmunol 33(1):63\u201372. https:\/\/doi.org\/10.1016\/0165-5728(91)90035-6. (PubMed PMID: 1829093)","journal-title":"J Neuroimmunol"},{"key":"13739_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/cells9040842","author":"FF Konen","year":"2020","unstructured":"Konen FF, Wurster U, Witte T, Jendretzky KF, Gingele S, Tumani H et al (2020) The impact of immunomodulatory treatment on kappa free light chains as biomarker in neuroinflammation. Cells. https:\/\/doi.org\/10.3390\/cells9040842. (Epub 20200331)","journal-title":"Cells"},{"issue":"7","key":"13739_CR23","doi-asserted-by":"publisher","DOI":"10.1111\/ene.70291","volume":"32","author":"F Duell","year":"2025","unstructured":"Duell F, H\u00f6gelin KA, Vlad B, Neidhart S, Khademi M, Jelcic I et al (2025) Kappa Free Light Chain Index correlates with prognostic biomarkers in multiple sclerosis and decreases slowly following treatment. Eur J Neurol 32(7):e70291. https:\/\/doi.org\/10.1111\/ene.70291. (PubMed PMID: 40643211; PubMed Central PMCID: PMC12247182.)","journal-title":"Eur J Neurol"},{"issue":"9","key":"13739_CR24","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1016\/s1474-4422(08)70192-3","volume":"7","author":"D Franciotta","year":"2008","unstructured":"Franciotta D, Salvetti M, Lolli F, Serafini B, Aloisi F (2008) B cells and multiple sclerosis. Lancet Neurol 7(9):852\u2013858. https:\/\/doi.org\/10.1016\/s1474-4422(08)70192-3. (PubMed PMID: 18703007.)","journal-title":"Lancet Neurol"},{"issue":"1-2","key":"13739_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jneuroim.2013.06.014","volume":"262","author":"A Petzold","year":"2013","unstructured":"Petzold A (2013) Intrathecal oligoclonal IgG synthesis in multiple sclerosis. J Neuroimmunol 262(1\u20132):1\u201310. https:\/\/doi.org\/10.1016\/j.jneuroim.2013.06.014. (Epub 20130726)","journal-title":"J Neuroimmunol"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-026-13739-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-026-13739-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-026-13739-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T09:09:31Z","timestamp":1774516171000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-026-13739-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["13739"],"URL":"https:\/\/doi.org\/10.1007\/s00415-026-13739-8","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"9 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"R.C. reports no disclosures. M.L. has received speaking honoraria from Novartis. C.F. has received travel grants and\/or attended conferences upon invitation from Merck, Biogen, Sanofi, Novartis, and Alexion, and has received speaking honoraria from Novartis, Sanofi Genzyme, and AstraZeneca. E.L. has received travel grants from Roche, teaching fees from Biogen, Merck Serono, Novartis, Neuraxpharm, and Bristol, and served as principal investigator in a Sanofi randomized controlled trial. G.N. reports no disclosures. S.G. reports no disclosures. M.P. reports no disclosures. M.C. reports no disclosures.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}],"article-number":"191"}}